Polymyositis: does it really exist as a distinct clinical su... : Current Opinion in Rheumatology
Polymyositis: does it really exist as a distinct clinical subset? : Current Opinion in …

Purpose of review To identify clues to disease activity and discuss therapy options. Recent
findings The diagnostic evaluation includes documenting symmetrical proximal muscle …

Idiopathic inflammatory myopathies (IIMs) are a heterogeneous group of muscle disorders
including adult and juvenile dermatomyositis, polymyositis, immune-mediated necrotising …

Objective To assess the long-term outcome in patients with Idiopathic Inflammatory
Myopathies (IIM), focusing on damage and activity disease indexes using artificial …

The COVID-19 pandemic forces the whole rheumatic and musculoskeletal diseases
community to reassemble established treatment and research standards. Digital …

Myositis is a rare muscle disorder resulting from the immune system's attack on the muscle
cells, leading to muscle weaknesses. A precise and early diagnosis of the illness is crucial …

Psoriatic arthritis (PsA) is a chronic inflammatory disease that develops in up to 30% of
patients with psoriasis. In the vast majority of cases, cutaneous symptoms precede …

Myositis is the inflammation of the muscles that can arise from various sources with diverse
symptoms and require different treatments. For treatment to achieve optimal results, it is …

A retrospective cohort study in Chinese patients with adult polymyositis and dermatomyositis:
risk of comorbidities and subclass Page 1 Clinical and Experimental Rheumatology 2022 …

Fetal growth restriction (FGR) affects 5–10% of pregnancies, is the largest contributor to fetal
death, and can have long-term consequences for the child. Implementation of a standard …